BioCentury
ARTICLE | Clinical News

MedImmune Inc., National Heart, Lung, and Blood Institute regulatory update

June 10, 1996 7:00 AM UTC

MEDI said U.S. Patent No. 5,508,186 issued covering empty B19 parvovirus capsids. MEDI has an exclusive worldwide license to the patent, which issued to NHLBI. MEDI uses the technology in MEDI-491, a ...